MK0686 in Postsurgery Dental Pain

This study has been completed.
Information provided by:
Merck Sharp & Dohme Corp. Identifier:
First received: September 19, 2007
Last updated: NA
Last verified: September 2007
History: No changes posted

To compare the pain relieving effect of MK0686 to placebo or ibuprofen after dental surgery.

Condition Intervention Phase
Pain, Postoperative
Drug: MK0686
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double-Blind
Primary Purpose: Treatment

Further study details as provided by Merck Sharp & Dohme Corp.:

Study Start Date: June 2004
Study Completion Date: June 2004

Ages Eligible for Study:   18 Years to 45 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Men and women ages 18-45 years who are scheduled to have 2 or more third molars (wisdom teeth) removed
  • Patients must agree to remain in the clinic for 24 hours after surgery

Exclusion Criteria:

  • Patient has history of heart disease, asthma, pulmonary disease
  • Patient must discontinue use of certain pain medicines 24-72 hours prior to the surgery
  Contacts and Locations
Please refer to this study by its identifier: NCT00533403

Sponsors and Collaborators
Merck Sharp & Dohme Corp.
Study Director: Medical Monitor Merck Sharp & Dohme Corp.
  More Information

No publications provided Identifier: NCT00533403     History of Changes
Other Study ID Numbers: 2007_617
Study First Received: September 19, 2007
Last Updated: September 19, 2007
Health Authority: United States: Food and Drug Administration

Additional relevant MeSH terms:
Pain, Postoperative
Postoperative Complications
Pathologic Processes
Signs and Symptoms processed this record on April 17, 2014